Extra Skeletal Ewing's Sarcoma: a Case Report.

J Dent (Shiraz)

Postgraduate Student, Dept. of Oral and Maxillofacial Pathology, Dental School Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Published: March 2020

Ewing's sarcoma is an uncommon malignancy primarily affecting bone tissue and usually occurs in adolescents and young adults. This paper reports a rare case of extra-skeletal Ewing's sarcoma of the oral cavity soft tissue. In the clinical examination, a mass of 1.5×1.5cm in diameter was observed in the right mandibular vestibule. Radiographic examination revealed no involvement of mandible. Microscopically, the tumor was composed of malignant small round cell tumor that exhibited immunoreactivity for CD99. Enucleation surgery under local anesthesia was performed for the patient and prognosis was excellent. The patient remained symptom-free after 13 months of follow-up.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036358PMC
http://dx.doi.org/10.30476/DENTJODS.2019.44908DOI Listing

Publication Analysis

Top Keywords

ewing's sarcoma
12
extra skeletal
4
skeletal ewing's
4
sarcoma case
4
case report
4
report ewing's
4
sarcoma uncommon
4
uncommon malignancy
4
malignancy bone
4
bone tissue
4

Similar Publications

Background: Ewing sarcoma of the head and neck (ES-HN) is a rare subsite of ES, where therapeutic outcomes need to be explored further.

Methods: This retrospective study includes ES-HN patients registered at our center between 2003 and 2019. Demographic details and treatment outcomes were recorded from the hospital database.

View Article and Find Full Text PDF

The goal of this study was to summarize the radiological findings and clinical characteristics of mediastinal Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET) in children. A retrospective review was conducted on the clinical and imaging data of 6 children with primary mediastinal ES/PNET that was confirmed by pathology. There were 3 girls and 3 boys in this study, aged between 2 and 11 years old.

View Article and Find Full Text PDF

Background: GALOP investigators developed a prospective cooperative protocol for localized Ewing sarcoma (ES) incorporating interval-compressed chemotherapy (VDC/IE, vincristine, doxorubicin, cyclophosphamide/ifosfamide and etoposide). After completing conventional treatment, patients were randomized to 1 year of metronomic chemotherapy (vinblastine and cyclophosphamide).

Methods: Phase III randomized prospective trial.

View Article and Find Full Text PDF

Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial.

Pediatr Blood Cancer

January 2025

Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Background: Several studies have shown that the intensity of treatment in Ewing sarcoma has an impact on outcome. The present trial tested the non-inferiority of intensive, shorter, induction chemotherapy (25 weeks total treatment time) compared to the standard treatment (37 weeks) in non-metastatic Ewing sarcoma (ES) at onset.

Procedure: This national, multicenter, parallel, randomized, controlled, open-label, non-inferiority, phase III trial was conducted in 14 specialized hospitals in Italy.

View Article and Find Full Text PDF

This case report describes a 4.5-year-old girl diagnosed with a rare Undifferentiated Small Round Cell Sarcoma (USRCS) originating in the parapharyngeal space with multiple lung metastases. Diagnostic workups, including imaging, immunohistochemistry, and genetic sequencing, identified the tumor as an unclassified subtype of USRCS.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!